Plain-English translation of NCT05927584 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The LORENA trial is testing whether a minimally invasive local excision surgery—where only the tumor and a small margin of tissue are removed—is enough to treat very early rectal cancer without needing chemotherapy or radiation. Researchers want to learn whether this organ-preserving approach works safely and effectively for patients whose tumors meet strict criteria for low risk of spread.
Most rectal cancer patients currently need surgery to remove the entire rectum, which can affect bowel function and quality of life. This study exists to see whether carefully selected early-stage patients can avoid this major surgery and keep their rectum intact by using a gentler local removal technique instead.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive local excision surgery to remove your tumor while preserving your rectum. After surgery, you will be followed closely with visits and imaging at set intervals: at 30 days after surgery, then at 6, 12, 18, 24, and 36 months. During these visits, your medical team will monitor for any signs that the cancer has returned and will collect information about your recovery, bowel function, and overall health. The study lasts three years total.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Spain